Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 20 Dec 2023

The role of ARL4C in predicting prognosis and immunotherapy drug susceptibility in pan-cancer analysis

in Pharmacology of Anti-Cancer Drugs

Hanshu Zhao
Kaiqi Yang
Ziqi Yue
Ziyin Chen
Zhe Cheng
Hongcheng Sun
Changze Song

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1288492

2,712 views
6 citations

Original Research

Published on 20 Dec 2023

The categorizations of vasculogenic mimicry in clear cell renal cell carcinoma unveil inherent connections with clinical and immune features

in Pharmacology of Anti-Cancer Drugs

Bo Geng
Weiyang Liu
Jinpeng Wang
Wei Zhang
Zhuolun Li
Nan Zhang
Wenbin Hou
Enyang Zhao
Xuedong Li
Bosen You

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1333507

3,180 views
3 citations

Review

Published on 19 Dec 2023

Metabolic reprogramming in the tumor microenvironment: unleashing T cell stemness for enhanced cancer immunotherapy

in Pharmacology of Anti-Cancer Drugs

Youhan Liu
Tao Wang
Wen Ma
Zixuan Jia
Qinglu Wang
Maoling Zhang
Ying Luo
Hongmei Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1327717

3,410 views
5 citations

Editorial

Published on 18 Dec 2023

Editorial: Recent advances in small molecule-based targeted therapy for breast cancer

in Pharmacology of Anti-Cancer Drugs

Thet Thet Htar
Rakesh Naidu
Vuanghao Lim
Amit Kumar Pandey

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1343664

1,928 views
2 citations

Original Research

Published on 15 Dec 2023

Benefit assessment of extended dosing in cancer patients after their withdrawal from clinical trials

in Pharmacology of Anti-Cancer Drugs

Feng Yang
Zhe Huang
Jianfu Heng
Kunyan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1178002

1,203 views

Case Report

Published on 15 Dec 2023

Posterior reversible encephalopathy syndrome associated with use of anlotinib to treat squamous cell carcinoma of the cervix: case report and literature review

in Pharmacology of Anti-Cancer Drugs

Jietao Lin
Wenmin Chen
Sha Zhong
Kai Qian
Hanrui Chen
Lizhu Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1255785

1,562 views
1 citation

Systematic Review

Published on 14 Dec 2023

Effectiveness and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Songfei Han
Cuishan Guo
Zixuan Song
Ling Ouyang
Yizi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1330877

2,920 views
4 citations

Correction

Published on 14 Dec 2023

Corrigendum: Advances in the roles of glycyrrhizic acid in cancer therapy

in Pharmacology of Anti-Cancer Drugs

Yuqian Zhang
Zixuan Sheng
Jing Xiao
Yang Li
Jie Huang
Jinjing Jia
Xiansi Zeng
Li Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1345663

1,059 views
11 citations

Original Research

Published on 14 Dec 2023

Ansofaxine hydrochloride inhibits tumor growth and enhances Anti-TNFR2 in murine colon cancer model

in Pharmacology of Anti-Cancer Drugs

Qianyu Jing
Quan Wan
Yujie Nie
Junqian Luo
Xiangyan Zhang
Lan Zhu
Huan Gui
Linzhao Li
Chenglv Wang
Shuanghui Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1286061

7,445 views
7 citations

Mini Review

Published on 14 Dec 2023

Research progress of biomineralization for the diagnosis and treatment of malignant tumors

in Pharmacology of Anti-Cancer Drugs

Yulu Wu
Xun Pan
Huixu Xie
Lin Que
Xiufa Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1335019

1,654 views
4 citations

Original Research

Published on 13 Dec 2023

Iberverin exhibits antineoplastic activities against human hepatocellular carcinoma via DNA damage-mediated cell cycle arrest and mitochondrial-related apoptosis

in Pharmacology of Anti-Cancer Drugs

Yuting Zhang
Jiao Du
Libo Jin
Liying Pan
Xiufeng Yan
Sue Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1326346

1,914 views
5 citations

Case Report

Published on 12 Dec 2023

Lichenoid mucocutaneous reactions associated with sintilimab therapy in a non-small cell lung adenocarcinoma patient: case report and review

in Pharmacology of Anti-Cancer Drugs

Shuting Zhou
Zhenyu Zhang
Xiaodong Feng
Chengjian Zhao
Lu Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1276788

1,624 views
2 citations

Original Research

Published on 12 Dec 2023

NOP58 induction potentiates chemoresistance of colorectal cancer cells through aerobic glycolysis as evidenced by proteomics analysis

in Pharmacology of Anti-Cancer Drugs

Feifei Wang
Bin Yu
Quanyong Yu
Guanglin Wang
Baokun Li
Ganlin Guo
Handong Wang
Hui Shen
Shujin Li
Chunling Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1295422

2,282 views
3 citations

Case Report

Published on 11 Dec 2023

Case report: SAF-189s is a potent inhibitor in a lorlatinib-resistant NSCLC patient with acquired compound mutations ALK L1196M and D1203N

in Pharmacology of Anti-Cancer Drugs

Na Li
Huihui Li
Ding Wang
Xiaoling Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1197163

1,672 views
1 citation

Original Research

Published on 11 Dec 2023

Effect of Danshen for improving clinical outcomes in patients with bladder cancer: a retrospective, population-based study

in Pharmacology of Anti-Cancer Drugs

Yi-Hsin Chen
Chih-Tsung Chen
Han-Ping Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1260683

2,121 views
4 citations

Review

Published on 08 Dec 2023

Recent progress in the role of endogenous metal ions in doxorubicin-induced cardiotoxicity

in Pharmacology of Anti-Cancer Drugs

Ni Zhou
Shanshan Wei
Taoli Sun
Suifen Xie
Jian Liu
Wenqun Li
Bikui Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1292088

3,876 views
9 citations